omniture

Dehaier Strengthens Intellectual Property Portfolio

2011-06-27 19:04 1640

BEIJING, June 27, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it was granted three new patents by State Intellectual Property Office of the People's Republic of China ("SIPO"). The patent awards were related to the design of Dehaier's Sleep Diagnostic and Continuous Positive Airway Pressure ("CPAP") homecare medical products and Medical-grade Air Compressor. These patents were issued in June 2011 and are valid for 10 years.

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO )

Design patents are granted to products that incorporate unique shapes, patterns, colors or combinations of features that strengthen a product's brand value upon commercialization. According to Patent Law of People's Republic of China, design patents are protected and defensible under national Intellectual Property Law.

"Innovation through continued R&D is key to supporting growth in our self-branded homecare business, and we believe these patent awards further protect our ability to provide the market with proprietary best-in-breed products. Developing new designs and enriching self-branded product offerings in the homecare segment is one of our key growth strategies to meet diversified market needs with portable, personalized and differential products," said Mr. Ping Chen, CEO of Dehaier, "These new patents bring our total intellectual property holdings to five patents and five software copyrights, in addition to other proprietary technology, such as trade secrets. Additionally, we currently have three pending patents and six pending software copyrights applications with SIPO for homecare products. We will continue to strengthen our R&D capabilities and plan to continue to build our intellectual property portfolio to increase our brand recognition, gain market share and continue growing our business. "

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on five patents and five software copyrights; additionally we have three pending patents and six pending software copyrights, and proprietary technology. More information may be found at http://www.chinadhr.com.

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.


Contact Us


In the US:

The Piacente Group, Inc.

Investor Relations

Brandi Floberg or Lee Roth

Phone: +1-212-481-2050

Email: dehaier@tpg-ir.com


In China:

The Piacente Group, Inc.

Investor Relations

Wendy Sun

Phone: +86-10-6590-7991

Email: dehaier@tpg-ir.com


Dehaier Medical Systems Limited

Rita Liu

CFO

Phone: +86-10-8844-5026

Email: liuz@dehaier.com.cn




Source: Dehaier Medical Systems Ltd.
Related Stocks:
NASDAQ:DHRM
collection